Edwin Avery, MD
Anesthesiology · Cleveland, OHNPI 1639157241
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $120,718 of the $194,006 with a category attached, or 62.2%. 11 manufacturers reported payments, led by Chiesi USA, Inc. at 37.3% of the total. Reporting peaked in 2019 at $87,577 and has fallen 99.9% since, to $100 in 2025. Among anesthesiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 215 payments — averaging $902.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Chiesi USA, Inc.$72K
- Medtronic$72K
- Covidien LP$33K
- Acelrx Pharmaceuticals, Inc.$14K
- Chugai Pharmaceutical Co., Ltd.$1K
- Ancora Heart, Inc.$536
- plus $302 from 5 others
What the payments were for
- Consulting fees$44,00923%
- Speaking & faculty fees$120,71862%
- Travel & lodging$25,17413%
- Food & beverage$4,0982%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Chiesi USA, Inc. | 121 | $72,361 |
| Medtronic(2 entities) | 62 | $71,872 |
| Covidien LP | 12 | $33,473 |
| Acelrx Pharmaceuticals, Inc. | 13 | $14,422 |
| Chugai Pharmaceutical Co., Ltd. | 1 | $1,040 |
| Ancora Heart, Inc. | 1 | $536 |
| Portola Pharmaceuticals, LLC | 1 | $119 |
| La Jolla Pharmaceutical Company | 1 | $81 |
| Livanova USA, Inc. | 1 | $63 |
| Merck | 1 | $23 |
| Avanos Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLEVIPREX$69,295
- CoreValve Evolut$34,432
- INVOS$19,546
- DSUVIA$14,379
- Nellcor$10,782
- CLEVIPREX 50MG/100ML$3,181
- BIS$1,379
- COREVALVE EVOLUT R$1,250
- Non-Covered Product$1,040
- CLEVIPREX 25MG/50ML$774
- KENGREAL 50MG/10ML L$120
- ANDEXXA$119
How this compares
$194,006 in reported general payments places this provider in the 95th percentile of 1,623 anesthesiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Cleveland
- Sabry AyadCleveland$427K
- Hesham ElsharkawyCleveland$189K
- Basem AbdelmalakCleveland$147K
- Daniel SesslerCleveland$140K
- Andrew ShawCleveland$112K
- Michael SmithCleveland$75K
- Adi CosicCleveland$57K
- Sameam ShahrestaniCleveland$57K
- Peter SchoenwaldCleveland$55K
- Mark ChmielaCleveland$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.